Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29905593 | 1.00 | THRB (0.46) | THRBLMNACA1CA2MMP1 | |
| SCHEMBL7602959 | 1.00 | THRB (0.46) | THRBLMNACA1CA2MMP1 | |
| SCHEMBL9424657 | 1.00 | THRB (0.46) | THRBLMNACA1CA2MMP1 | |
| SCHEMBL333072 | 0.97 | THRB (0.42) | THRBLMNA | |
| SCHEMBL333073 | 0.97 | THRB (0.42) | THRBLMNA | |
| SCHEMBL9211057 | 0.97 | THRB (0.42) | THRBLMNA | |
| Ethane SCHEMBL28051354 | 0.95 | THRB (0.42) | THRBLMNA | |
| SCHEMBL8380164 | 0.91 | THRB (0.52) | THRBLMNACA1CA2MMP1 | |
| SCHEMBL5374510 | 0.91 | THRB (0.52) | THRBLMNACA1CA2MMP1 | |
| SCHEMBL5365862 | 0.91 | THRB (0.52) | THRBLMNACA1CA2MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018165608-A1 | PROCESSES FOR PREPARING PARTIALLY FLUORINATED EPOXIDES AND PERFLUORINATED EPOXIDES AND COMPOSITIONS RELATED THERETO | THE CHEMOURS COMPANY FC, LLC (US) | 2018-09-13 | — | — | WO | claimed |
| CN-105637059-A | Use of alkyl perfluoroalkene ethers and mixtures thereof in high temperature heat pumps | CHEMOURS CO FC LLC | 2016-06-01 | — | — | CN | claimed |
| CN-103827069-B | The method of separated portion in alkyl perfluoroolefine ether is produced | E. I. DU PONT DE NEMOURS AND CO. (US) | 2016-04-06 | — | — | CN | claimed |
| EP-2760814-B1 | PROCESSES FOR SEPARATING COMPONENTS IN ALKYL PERFLUOROALKENE ETHER PRODUCTION | DU PONT (US) | 2015-10-28 | — | — | EP | claimed |
| EP-2760814-A1 | PROCESSES FOR SEPARATING COMPONENTS IN ALKYL PERFLUOROALKENE ETHER PRODUCTION | E. I. Du Pont de Nemours and Company (US) | 2014-08-06 | — | — | EP | claimed |
| CN-103827069-A | Processes for separating components in alkyl perfluoroalkene ether production | DU PONT | 2014-05-28 | — | — | CN | claimed |
| US-8592630-B2 | Processes for separating components in alkyl perfluoroalkene ether production | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-11-26 | — | — | US | claimed |
| WO-2013086264-A1 | COMPOSITION COMPRISING FLUOROALKYL PERFLUOROALKENE ETHERS AND USES THEREOF | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-13 | — | — | WO | claimed |
| WO-2013049245-A1 | PROCESSES FOR SEPARATING COMPONENTS IN ALKYL PERFLUOROALKENE ETHER PRODUCTION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-04-04 | — | — | WO | claimed |
| US-20130079558-A1 | PROCESSES FOR SEPARATING COMPONENTS IN ALKYL PERFLUOROALKENE ETHER PRODUCTION | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-03-28 | — | — | US | claimed |
| CN-102317245-A | Novel alkyl perfluoroalkene ethers and uses thereof | DU PONT | 2012-01-11 | — | — | CN | claimed |
| EP-2396294-A2 | NOVEL ALKYL PERFLUOROALKENE ETHERS AND USES THEREOF | E. I. du Pont de Nemours and Company (US) | 2011-12-21 | — | — | EP | claimed |
| US-20110282104-A1 | NOVEL ALKYL PERFLUOROALKENE ETHERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-17 | — | — | US | claimed |
| US-20100209600-A1 | NOVEL ALKYL PERFLUOROALKENE ETHERS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-08-19 | — | — | US | claimed |
| WO-2010094019-A2 | NOVEL ALKYL PERFLUOROALKENE ETHERS AND USES THEREOF | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-08-19 | — | — | WO | claimed |
| US-20210139441-A1 | USES OF FLUORINATED EPOXIDES AND NOVEL MIXTURES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-05-13 | — | — | US | disclosed |
| US-20190211247-A1 | Use of Alkyl Perfluoroalkene Ethers and Mixtures Thereof in High Temperature Heat Pumps | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2019-07-11 | — | — | US | disclosed |
| US-5268122-A | Azeotropic mixture | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-12-07 | — | — | US | disclosed |
| CN-1070903-A | Gm-dihydropolyfluoroalkanes and preparation method thereof and cleaning use | DU PONT (US) | 1993-04-14 | — | — | CN | disclosed |
| WO-1993005002-A2 | GEM-DIHYDROPOLYFLUOROALKANES AND MONOHYDROPOLYFLUOROALKENES, PROCESSES FOR THEIR PRODUCTION, AND USE OF GEM-DIHYDROPOLYFLUOROALKANES IN CLEANING COMPOSITIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-03-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210139441-A1 | USES OF FLUORINATED EPOXIDES AND NOVEL MIXTURES THEREOF | PFAS, PFN1, FRG1 | THRB 3866/4885LMNA 3631/4885CA1 1382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.